Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an CZY Biotech is a China-based company engaged in the research, development, production, and sales of health and medical products. It operates as an OEM/contract manufacturer with more than 10 production lines. The company’s annual output value is below US$1 million. There is no public clinical data or indication that it develops prescription therapeutics or conducts clinical trials; its focus appears to be on commercial-scale manufacturing for health-related products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an CZY Biotech.